Tag: eyes

Dylan Field’s IPO Dream — Figma’s Not a Sure Bet

Dylan Field's got that deer-in-the-headlights look on him when he logs onto our Zoom call. He’s fresh off launching Figma on the NYSE, defying...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsEyes

Director/PDMR Shareholding

Taboola Announces Inclusion in Russell 3000® and 2000® Index

Aptean Appoints Yama Habibzai as Chief Marketing Officer

Tag: eyes

Dylan Field’s IPO Dream — Figma’s Not a Sure Bet

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us